ClinConnect ClinConnect Logo
Search / Trial NCT04479683

COmparison Between Continued Inpatient Treatment Versus Day Patient Treatment in Early Onset Anorexia Nervosa

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 16, 2020

Trial Information

Current as of July 06, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the treatment of early onset anorexia nervosa (AN) in children aged 8 to 13 years. It compares two approaches: continued full-time hospitalization (FTH) and day hospitalization (DH) treatment. The researchers want to find out if they can shorten the time spent in the hospital and then provide ongoing care during the day, which may be just as effective but easier for the child and their family. The goal is to improve acceptance of treatment, support social and school integration, and reduce costs while ensuring children receive the necessary care for their condition.

To participate in this trial, children must be diagnosed with anorexia nervosa, be between the ages of 8 and 13, and require hospitalization based on certain health criteria. They also need parental consent and have to be covered by social security. Participants can expect to be part of a study that aims to improve treatment options for young children with severe anorexia nervosa, helping them recover in a more supportive environment while minimizing the challenges associated with long-term hospitalization.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Anorexia Nervosa according to diagnostic mental disorders(DSM 5) criteria;
  • Age at diagnosis 8 to 13 years inclusive;
  • Indication for full-time hospitalisation according to supreme health authority (HAS 2010) criteria, see appendix;
  • First hospitalization in the Eating Disorders (ED) unit of the Child and Adolescent Psychiatry Department at Robert Debré Hospital.
  • Informed consent of the holder(s) of parental authority
  • Patient affiliated to a social security
  • Exclusion Criteria:
  • Other early onset eating disorders (ARFID to DSM 5 criteria) ;
  • Underlying unbalanced somatic disease (especially gastroenterological);
  • Psychiatric indication for continued hospitalisation (in particular significant suicidal risk according to the psychiatric criteria for full-time hospitalisation for anorexia nervosa of the HAS, 2010, cf. appendix)
  • Environmental indication for continued full-time hospitalization according to the HAS environmental criteria for full-time hospitalization for anorexia nervosa, 2010, cf. appendix) ;
  • History of full-time hospitalisation in our ED unit.

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Stordeur Coline, MD

Principal Investigator

APHP

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials